121 related articles for article (PubMed ID: 2141511)
1. Blood transfusion and prognosis in Dukes' B and C colorectal cancer.
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Sørensen F; Bone J; Jacobsen NO; Sell A; Overgaard J; Bertelsen K
Eur J Cancer; 1990 Apr; 26(4):457-63. PubMed ID: 2141511
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
4. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
6. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
7. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Sørensen F; Bone J; Jacobsen NO; Sell A; Overgaard J; Bertelsen K
Br J Cancer; 1992 Jan; 65(1):102-7. PubMed ID: 1733432
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
9. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer--a multivariate analysis of prognostic factors.
Wolters U; Stützer H; Keller HW; Schröder U; Pichlmaier H
Eur J Surg Oncol; 1996 Dec; 22(6):592-7. PubMed ID: 9005146
[TBL] [Abstract][Full Text] [Related]
12. The value of immunohistochemistry for collagen IV expression in colorectal carcinomas.
Offerhaus GJ; Giardiello FM; Bruijn JA; Stijnen T; Molyvas EN; Fleuren GJ
Cancer; 1991 Jan; 67(1):99-105. PubMed ID: 1985727
[TBL] [Abstract][Full Text] [Related]
13. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
[TBL] [Abstract][Full Text] [Related]
15. The association of perioperative blood transfusion with colorectal cancer recurrence.
Tartter PI
Ann Surg; 1992 Dec; 216(6):633-8. PubMed ID: 1466616
[TBL] [Abstract][Full Text] [Related]
16. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Soerensen F; Bone J; Jacobsen NO; Overgaard J; Sell A; Bertelsen K
Br J Cancer; 1988 Aug; 58(2):195-201. PubMed ID: 3166910
[TBL] [Abstract][Full Text] [Related]
17. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators.
Heimann TM; Oh SC; Martinelli G; Szporn A; Luppescu N; Lembo CA; Kurtz RJ; Fasy TM; Greenstein AJ
Am J Surg; 1992 Jul; 164(1):13-7. PubMed ID: 1626600
[TBL] [Abstract][Full Text] [Related]
18. Peri-operative blood transfusions in colorectal cancer.
Vente JP; Wiggers T; Weidema WF; Jeekel J; Obertop H
Eur J Surg Oncol; 1989 Aug; 15(4):371-4. PubMed ID: 2668037
[TBL] [Abstract][Full Text] [Related]
19. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma.
Wobbes T; Joosen KH; Kuypers HH; Beerthuizen GI; Theeuwes GM
Dis Colon Rectum; 1989 Sep; 32(9):743-8. PubMed ID: 2758942
[TBL] [Abstract][Full Text] [Related]
20. Plasma tetranectin and colorectal cancer.
Høgdall CK; Christiansen M; Nørgaard-Pedersen B; Bentzen SM; Kronborg O; Clemmensen I
Eur J Cancer; 1995 Jun; 31A(6):888-94. PubMed ID: 7646916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
